Cytisinicline

Smoking cessation

Manufacturer: Achieve Life Sciences
Regulatory submission: NDA resubmission planned for the fourth quarter of 2026
Launch: Anticipated after potential approval in the first half of 2027
Last updated: September 19, 2026

Section

Product information and disease description Product description Product information

Indication

1 evidence topic · 1 source

Proposed U.S. indication

“smoking cessation in adults” (opens the source at this quote in a new tab)